Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14046 | 732 | 35.2 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
438 | 15587 | OXYTOCIN//VASOPRESSIN//SUPRAOPTIC NUCLEUS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VASODILATORY SHOCK | Author keyword | 34 | 79% | 3% | 22 |
2 | VASOPLEGIC SYNDROME | Author keyword | 20 | 100% | 1% | 9 |
3 | VASOPLEGIA | Author keyword | 18 | 61% | 3% | 19 |
4 | TERLIPRESSIN | Author keyword | 9 | 20% | 6% | 41 |
5 | VASOPLEGIC SHOCK | Author keyword | 4 | 75% | 0% | 3 |
6 | VASOPRESSORS | Author keyword | 4 | 15% | 3% | 22 |
7 | ANTIDIURECTIC HORMONE | Author keyword | 3 | 100% | 0% | 3 |
8 | PHYSIOL RENALE VASC | Address | 3 | 100% | 0% | 3 |
9 | ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL INHIBITION | Author keyword | 2 | 67% | 0% | 2 |
10 | CATECHOLAMINE RESISTANCE | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VASODILATORY SHOCK | 34 | 79% | 3% | 22 | Search VASODILATORY+SHOCK | Search VASODILATORY+SHOCK |
2 | VASOPLEGIC SYNDROME | 20 | 100% | 1% | 9 | Search VASOPLEGIC+SYNDROME | Search VASOPLEGIC+SYNDROME |
3 | VASOPLEGIA | 18 | 61% | 3% | 19 | Search VASOPLEGIA | Search VASOPLEGIA |
4 | TERLIPRESSIN | 9 | 20% | 6% | 41 | Search TERLIPRESSIN | Search TERLIPRESSIN |
5 | VASOPLEGIC SHOCK | 4 | 75% | 0% | 3 | Search VASOPLEGIC+SHOCK | Search VASOPLEGIC+SHOCK |
6 | VASOPRESSORS | 4 | 15% | 3% | 22 | Search VASOPRESSORS | Search VASOPRESSORS |
7 | ANTIDIURECTIC HORMONE | 3 | 100% | 0% | 3 | Search ANTIDIURECTIC+HORMONE | Search ANTIDIURECTIC+HORMONE |
8 | ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL INHIBITION | 2 | 67% | 0% | 2 | Search ADENOSINE+TRIPHOSPHATE+SENSITIVE+POTASSIUM+CHANNEL+INHIBITION | Search ADENOSINE+TRIPHOSPHATE+SENSITIVE+POTASSIUM+CHANNEL+INHIBITION |
9 | CATECHOLAMINE RESISTANCE | 2 | 67% | 0% | 2 | Search CATECHOLAMINE+RESISTANCE | Search CATECHOLAMINE+RESISTANCE |
10 | INOTROPE SCORE | 2 | 50% | 0% | 3 | Search INOTROPE+SCORE | Search INOTROPE+SCORE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LOW DOSE VASOPRESSIN | 118 | 80% | 10% | 74 |
2 | VASODILATORY SHOCK | 87 | 65% | 11% | 83 |
3 | ADVANCED VASODILATORY SHOCK | 84 | 77% | 8% | 57 |
4 | VASODILATORY SEPTIC SHOCK | 51 | 69% | 6% | 44 |
5 | SEVERE SEPTIC SHOCK | 19 | 58% | 3% | 22 |
6 | RESISTANT SEPTIC SHOCK | 19 | 71% | 2% | 15 |
7 | POSTCARDIOTOMY SHOCK | 17 | 68% | 2% | 15 |
8 | MILRINONE INDUCED HYPOTENSION | 15 | 82% | 1% | 9 |
9 | DOSE VASOPRESSIN | 13 | 69% | 2% | 11 |
10 | INTRACTABLE HYPOTENSION | 11 | 100% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cardiac Vasoplegia Syndrome: Pathophysiology, Risk Factors and Treatment | 2015 | 1 | 49 | 53% |
Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis | 2012 | 15 | 30 | 67% |
BLOOD PRESSURE TARGETS FOR VASOPRESSOR THERAPY: A SYSTEMATIC REVIEW | 2015 | 2 | 41 | 27% |
Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials | 2012 | 10 | 23 | 78% |
The vasopressin system - Physiology and clinical strategies | 2006 | 107 | 131 | 37% |
Vasopressin: Mechanisms of action on the vasculature in health and in septic shock | 2007 | 71 | 100 | 35% |
Arginine vasopressin in 316 patients with advanced vasodilatory shock | 2005 | 104 | 36 | 53% |
Renin-angiotensin system antagonists in the perioperative setting: clinical consequences and recommendations for practice | 2011 | 23 | 67 | 40% |
Bench-to-bedside review: Vasopressin in the management of septic shock | 2011 | 16 | 128 | 52% |
Vasopressors for hypotensive shock | 2011 | 14 | 50 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHYSIOL RENALE VASC | 3 | 100% | 0.4% | 3 |
2 | INVEST INTENS CARE UNIT | 2 | 16% | 1.5% | 11 |
3 | KELOWNA GEN HOSP | 1 | 50% | 0.3% | 2 |
4 | ANESZTEZIOL INTENZ TER IAS KLIN | 1 | 33% | 0.4% | 3 |
5 | GRP RECH PHYSIOPATHOL P | 1 | 30% | 0.4% | 3 |
6 | GEN SURG INTENS CARE MED | 1 | 11% | 1.1% | 8 |
7 | MEF | 1 | 14% | 0.7% | 5 |
8 | ANAESTHESIOL PERIOPERAT GEN INTENS CARE ME | 1 | 50% | 0.1% | 1 |
9 | BK21 PROGRAM INTEGRAT NETWORK SYST VETERINARIANS | 1 | 50% | 0.1% | 1 |
10 | D ING HOSP 2 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000260511 | COPEPTIN//BRAHMS AKTIENGESELL//RULE OUT |
2 | 0.0000163445 | YM087//OPC 21268//SR 49059 |
3 | 0.0000128414 | DOPEXAMINE//GASTRIC TONOMETRY//INTRAMUCOSAL PH |
4 | 0.0000126843 | SURVIVING SEPSIS CAMPAIGN//SEVERE SEPSIS//EARLY GOAL DIRECTED THERAPY |
5 | 0.0000103382 | SIDESTREAM DARK FIELD IMAGING//ORTHOGONAL POLARIZATION SPECTRAL IMAGING//SDF IMAGING |
6 | 0.0000098659 | AMINOETHYL ISOTHIOUREA//VASCULAR HYPOREACTIVITY//N G METHYL L ARGININE HYDROCHLORIDE |
7 | 0.0000090239 | CARDIOPULMONARY RESUSCITATION//PERIODIC ACCELERATION//OPEN CHEST CPR |
8 | 0.0000085213 | FENOLDOPAM//LOW DOSE DOPAMINE//FENOLDOPAM MESYLATE |
9 | 0.0000058943 | SEPTIC CARDIOMYOPATHY//CARDIONOME//MYOCARDIAL DEPRESSION |
10 | 0.0000055971 | DESMOPRESSIN//DDAVP//PHARMACOLOGY DESMOPRESSIN |